GSK
718 hedge funds and large institutions have $8.72B invested in GSK in 2015 Q4 according to their latest regulatory filings, with 93 funds opening new positions, 233 increasing their positions, 274 reducing their positions, and 69 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
2% more capital invested
Capital invested by funds: $8.53B → $8.72B (+$189M)
0.12% less ownership
Funds ownership: 3.66% → 3.54% (-0.12%)
15% less repeat investments, than reductions
Existing positions increased: 233 | Existing positions reduced: 274
Holders
718
Holding in Top 10
10
Calls
$221M
Puts
$120M
Top Buyers
| 1 | +$92.9M | |
| 2 | +$48.1M | |
| 3 | +$34M | |
| 4 |
JHC
JFB Holdings Corp
Atlanta,
Georgia
|
+$32.3M |
| 5 |
Citigroup
New York
|
+$23.4M |
Top Sellers
| 1 | -$128M | |
| 2 | -$57.2M | |
| 3 | -$50.6M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$32.3M |
| 5 |
O
OppenheimerFunds
New York
|
-$30.6M |